These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 9527801

  • 1. Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of DNA topoisomerase IV associated with quinolone resistance in Enterococcus faecalis.
    Kanematsu E, Deguchi T, Yasuda M, Kawamura T, Nishino Y, Kawada Y.
    Antimicrob Agents Chemother; 1998 Feb; 42(2):433-5. PubMed ID: 9527801
    [Abstract] [Full Text] [Related]

  • 2. Alteration in the GyrA subunit of DNA gyrase and the ParC subunit of DNA topoisomerase IV in quinolone-resistant clinical isolates of Staphylococcus epidermidis.
    Li Z, Deguchi T, Yasuda M, Kawamura T, Kanematsu E, Nishino Y, Ishihara S, Kawada Y.
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3293-5. PubMed ID: 9835531
    [Abstract] [Full Text] [Related]

  • 3. Alterations in GyrA and ParC associated with fluoroquinolone resistance in Enterococcus faecium.
    el Amin NA, Jalal S, Wretlind B.
    Antimicrob Agents Chemother; 1999 Apr; 43(4):947-9. PubMed ID: 10103206
    [Abstract] [Full Text] [Related]

  • 4. In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV.
    Yasuda M, Fukuda H, Yokoi S, Ishihara S, Kawada Y, Deguchi T.
    J Urol; 2000 Sep; 164(3 Pt 1):847-51. PubMed ID: 10953166
    [Abstract] [Full Text] [Related]

  • 5. Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant clinical isolates of Klebsiella pneumoniae.
    Deguchi T, Fukuoka A, Yasuda M, Nakano M, Ozeki S, Kanematsu E, Nishino Y, Ishihara S, Ban Y, Kawada Y.
    Antimicrob Agents Chemother; 1997 Mar; 41(3):699-701. PubMed ID: 9056017
    [Abstract] [Full Text] [Related]

  • 6. Quinolone-resistant Neisseria gonorrhoeae: correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles.
    Deguchi T, Yasuda M, Nakano M, Ozeki S, Ezaki T, Saito I, Kawada Y.
    Antimicrob Agents Chemother; 1996 Apr; 40(4):1020-3. PubMed ID: 8849219
    [Abstract] [Full Text] [Related]

  • 7. Inhibitory activities of quinolones against DNA gyrase and topoisomerase IV of Enterococcus faecalis.
    Onodera Y, Okuda J, Tanaka M, Sato K.
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1800-4. PubMed ID: 12019093
    [Abstract] [Full Text] [Related]

  • 8. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.
    Deguchi T, Yasuda M, Nakano M, Ozeki S, Kanematsu E, Nishino Y, Ishihara S, Kawada Y.
    J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424
    [Abstract] [Full Text] [Related]

  • 9. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones.
    Ferrero L, Cameron B, Manse B, Lagneaux D, Crouzet J, Famechon A, Blanche F.
    Mol Microbiol; 1994 Aug; 13(4):641-53. PubMed ID: 7997176
    [Abstract] [Full Text] [Related]

  • 10. Analysis by PCR and direct DNA sequencing of gyrA mutations associated with fluoroquinolone resistance in Enterococcus faecalis.
    Korten V, Huang WM, Murray BE.
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2091-4. PubMed ID: 7811024
    [Abstract] [Full Text] [Related]

  • 11. Cloning and characterization of the parC and parE genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone resistance.
    Pan XS, Fisher LM.
    J Bacteriol; 1996 Jul; 178(14):4060-9. PubMed ID: 8763932
    [Abstract] [Full Text] [Related]

  • 12. Antimicrobial activity of a new fluoroquinolone, DU-6859a, against quinolone-resistant clinical isolates of Neisseria gonorrhoeae with genetic alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV.
    Deguchi T, Yasuda M, Nakano M, Kanematsu E, Ozeki S, Ishihara S, Saito I, Kawada Y.
    J Antimicrob Chemother; 1997 Feb; 39(2):247-9. PubMed ID: 9069547
    [Abstract] [Full Text] [Related]

  • 13. Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii.
    Vila J, Ruiz J, Goñi P, Jimenez de Anta T.
    J Antimicrob Chemother; 1997 Jun; 39(6):757-62. PubMed ID: 9222045
    [Abstract] [Full Text] [Related]

  • 14. Mutations in the gyrA and parC genes associated with fluoroquinolone resistance in clinical isolates of Citrobacter freundii.
    Nishino Y, Deguchi T, Yasuda M, Kawamura T, Nakano M, Kanematsu E, Ozeki S, Kawada Y.
    FEMS Microbiol Lett; 1997 Sep 15; 154(2):409-14. PubMed ID: 9311142
    [Abstract] [Full Text] [Related]

  • 15. Mutations in topoisomerase IV and DNA gyrase of Staphylococcus aureus: novel pleiotropic effects on quinolone and coumarin activity.
    Fournier B, Hooper DC.
    Antimicrob Agents Chemother; 1998 Jan 15; 42(1):121-8. PubMed ID: 9449271
    [Abstract] [Full Text] [Related]

  • 16. Association of alterations in ParC and GyrA proteins with resistance of clinical isolates of Enterococcus faecium to nine different fluoroquinolones.
    Brisse S, Fluit AC, Wagner U, Heisig P, Milatovic D, Verhoef J, Scheuring S, Köhrer K, Schmitz FJ.
    Antimicrob Agents Chemother; 1999 Oct 15; 43(10):2513-6. PubMed ID: 10508034
    [Abstract] [Full Text] [Related]

  • 17. Fluoroquinolone resistance mutations in the parC, parE, and gyrA genes of clinical isolates of viridans group streptococci.
    González I, Georgiou M, Alcaide F, Balas D, Liñares J, de la Campa AG.
    Antimicrob Agents Chemother; 1998 Nov 15; 42(11):2792-8. PubMed ID: 9797205
    [Abstract] [Full Text] [Related]

  • 18. Rapid emergence of high-level resistance to quinolones in Campylobacter jejuni associated with mutational changes in gyrA and parC.
    Gibreel A, Sjögren E, Kaijser B, Wretlind B, Sköld O.
    Antimicrob Agents Chemother; 1998 Dec 15; 42(12):3276-8. PubMed ID: 9835526
    [Abstract] [Full Text] [Related]

  • 19. Sequence analysis of the gyrA and parC homologues of a wild-type strain of Vibrio parahaemolyticus and its fluoroquinolone-resistant mutants.
    Okuda J, Hayakawa E, Nishibuchi M, Nishino T.
    Antimicrob Agents Chemother; 1999 May 15; 43(5):1156-62. PubMed ID: 10223929
    [Abstract] [Full Text] [Related]

  • 20. Contribution of mutations in gyrA and parC genes to fluoroquinolone resistance of mutants of Streptococcus pneumoniae obtained in vivo and in vitro.
    Tankovic J, Perichon B, Duval J, Courvalin P.
    Antimicrob Agents Chemother; 1996 Nov 15; 40(11):2505-10. PubMed ID: 8913454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.